| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |